Suggestions
Mark Lehmkuhle
Accelerator Company at MedTech Innovator
Mark Lehmkuhle is a prominent figure in the MedTech industry, currently serving as the Accelerator Company at MedTech Innovator since June 2020. He holds a doctorate in bioengineering with a specialization in neural engineering, which he obtained from the University of Michigan College of Engineering. His academic background includes significant research experience, having worked as a Research Assistant Professor in the Department of Neurosurgery at the University of Utah from 2008 to 2017.14
In addition to his role at MedTech Innovator, Lehmkuhle is the CEO and founder of Epitel, Inc., a company focused on developing wearable, wireless EEG monitoring systems for seizure detection. Under his leadership, Epitel has secured substantial funding, including $5.8 million from the NIH for their pre-clinical wireless transmitter system, and has developed innovative products like the REMI platform, which aims to make EEG monitoring more accessible in clinical settings.134
Lehmkuhle's work emphasizes improving EEG equity and accessibility, reflecting his commitment to advancing medical technology for better patient outcomes.23
